Takayama Hitoshi, Nishimura Kazuo, Tsujimura Akira, Nakai Yasutomo, Nakayama Masashi, Aozasa Katsuyuki, Okuyama Akihiko, Nonomura Norio
Departments of Urology and Pathology (KA), Osaka University Graduate School of Medicine, Suita, Japan.
J Urol. 2009 Apr;181(4):1894-900. doi: 10.1016/j.juro.2008.11.090. Epub 2009 Feb 23.
Tumor associated macrophages can regulate the growth of various cancers positively or negatively. Intravesical bacillus Calmette-Guerin instillation is now gold standard treatment for bladder carcinoma in situ. We investigated the correlation between tumor associated macrophages infiltrating bladder carcinoma in situ and the response to intravesical bacillus Calmette-Guerin therapy.
We examined paraffin embedded tissues from 41 patients with bladder carcinoma in situ who received intravesical bacillus Calmette-Guerin therapy. Tumor associated macrophages were immunohistochemically stained by anti-CD68 monoclonal antibody.
The median number of tumor associated macrophages infiltrating among cancer cells and the number in the lamina propria were 4 and 24, respectively. Recurrent carcinoma in situ was found in 4.8% of cases with a lower cancer cell tumor associated macrophage count but in 47.6% of those with a higher cancer cell tumor associated macrophage count (less than 4 vs 4 or greater). Recurrence was found in 31.8% of patients with a lower lamina propria tumor associated macrophage count but in 21.1% of those with a higher lamina propria tumor associated macrophage count (less than 25 vs 25 or greater). The median ratio of tumor associated macrophages among cancer cells vs in the lamina propria was 0.2. Recurrence-free survival was significantly better in patients with a lower cancer cell tumor associated macrophage count (p = 0.0002). Those with a lower cancer cell-to-lamina propria tumor associated macrophage ratio had a higher recurrence-free rate (p <0.0001). Multivariate analysis revealed that the cancer cell tumor associated macrophage count and the cancer cell-to-lamina propria tumor associated macrophage ratio can be prognostic factors for bladder carcinoma in situ.
The count of tumor associated macrophages infiltrating the cancer area is useful for predicting the response of bladder carcinoma in situ to intravesical bacillus Calmette-Guerin instillation before treatment initiation.
肿瘤相关巨噬细胞可对多种癌症的生长产生正向或负向调节作用。膀胱内灌注卡介苗目前是原位膀胱癌的金标准治疗方法。我们研究了浸润原位膀胱癌的肿瘤相关巨噬细胞与膀胱内卡介苗治疗反应之间的相关性。
我们检查了41例接受膀胱内卡介苗治疗的原位膀胱癌患者的石蜡包埋组织。用抗CD68单克隆抗体对肿瘤相关巨噬细胞进行免疫组织化学染色。
浸润癌细胞的肿瘤相关巨噬细胞中位数为4,固有层中的数量为24。癌细胞肿瘤相关巨噬细胞计数较低的病例中,原位复发癌的发生率为4.8%,而计数较高的病例(小于4 vs 4或更高)中为47.6%。固有层肿瘤相关巨噬细胞计数较低的患者中,复发率为31.8%,而计数较高的患者(小于25 vs 25或更高)中为21.1%。癌细胞中肿瘤相关巨噬细胞与固有层中肿瘤相关巨噬细胞的中位数比例为0.2。癌细胞肿瘤相关巨噬细胞计数较低的患者无复发生存期明显更好(p = 0.0002)。癌细胞与固有层肿瘤相关巨噬细胞比例较低的患者无复发率更高(p <0.0001)。多变量分析显示,癌细胞肿瘤相关巨噬细胞计数和癌细胞与固有层肿瘤相关巨噬细胞比例可作为原位膀胱癌的预后因素。
在开始治疗前,浸润癌区的肿瘤相关巨噬细胞计数有助于预测原位膀胱癌对膀胱内卡介苗灌注的反应。